Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
S&R Hemoptic AB
AB
Active
Org 5591236210
Månskensvägen 179, 146 46
Tullinge
Construction of residential and non-residential buildings
·
NACE 4100
Est. 2017 · 8 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Construction of residential and non-residential buildings
/
S&R Hemoptic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
5M
4M
2M
1M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 4M
4M
2023
2024: 3M (-25% vs 2023)
3M
-25%
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
3 452
3 657
302
405
0
Staff expenses
−1 925
−1 525
−0
—
—
EBITDA
100
345
50
9
−1
Depreciation & amort.
—
—
—
−0
−0
EBIT
100
345
50
9
−1
Net financials
−13
−11
−0
—
—
Profit before tax
180
241
50
9
−1
Tax
−66
−58
−12
−8
−0
Net profit
114
183
38
1
−1
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
488
915
169
143
50
Equity
380
265
83
45
43
Long-term debt
—
—
—
0
0
Short-term debt
109
557
86
98
6
Total debt
109
557
86
98
6
Financial ratios
5-year trend
EBITDA margin
2,9 %
This company
15,8 %
Market median
This company
Market median
82% below market
2020
2024
Equity ratio
77,8 %
This company
38,2 %
Market median
This company
Market median
104% above market
2020
2024
Return on equity
30,1 %
This company
18,4 %
Market median
This company
Market median
64% above market
2020
2024
Net profit margin
3,3 %
This company
8,1 %
Market median
This company
Market median
59% below market
2020
2024
Asset turnover
7,07×
This company
1,12×
Market median
This company
Market median
531% above market
2020
2024
Debt / equity
0,29×
This company
0,62×
Market median
This company
Market median
53% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on S&R Hemoptic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
